Microfluidic probe can identify and isolate circulating tumor cells in blood samples

Written by Vivian Xie

A team of researchers from NYU Abu Dhabi (United Arab Emirates) has developed a new microfluidic system able to effectively isolate circulating tumor cells (CTCs) and clusters of CTCs from patients’ blood samples for the diagnosis of prostate cancer. The microfluidic system, called the Herringbone Microfluidic Probe (HB-MFP), operates as a channel-less microfluidic system. This aids in preventing several technical challenges usually associated with microfluidics. With a separated bottom capture substrate and top fluidics delivery system, the HB-MFP is able to remain mobile and scan the capture substrate as a patient’s blood sample moves over the board. The biofunctionalized substrate...

To view this content, please register now for access

It's completely free